Bildkälla: Stockfoto

Medivir: Strong Interim Readout from Fostrox - Redeye

Redeye comments on the strong results from the first interim readout of fostrox’ phase Ib/IIa study in liver cancer with six patients. We raise our base case.

Redeye comments on the strong results from the first interim readout of fostrox’ phase Ib/IIa study in liver cancer with six patients. We raise our base case.
Börsvärldens nyhetsbrev
ANNONSER